CIK: 0001823138 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $457,461 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INDIVIOR PLC | 13,668,919 | $325,320 | 71.1% | $23.80 | — | ORD | G4766E116 |
| ROIV | ROIVANT SCIENCES LTD | 7,909,591 | $79,729 | 17.4% | $5.20 | +72.0% | SHS | G76279101 |
| ABUS | ARBUTUS BIOPHARMA CORP | 8,280,818 | $19,046 | 4.2% | $2.69 | -3.2% | COM | 03879J100 |
| META | META PLATFORMS INC | 30,003 | $8,610 | 1.9% | $202.23 | +21.2% | CL A | 30303M102 |
| OMEX | ODYSSEY MARINE EXPL INC | 1,371,874 | $4,939 | 1.1% | $5.35 | -39.4% | COM NEW | 676118201 |
| ESPR | ESPERION THERAPEUTICS INC NE | 2,941,872 | $4,089 | 0.9% | $1.40 | 0.0% | COM | 29664W105 |
| HTZ | HERTZ GLOBAL HLDGS INC | 183,909 | $3,382 | 0.7% | $25.48 | -35.7% | COM NEW | 42806J700 |
| SONO | SONOS INC | 171,172 | $2,795 | 0.6% | $17.99 | -1.4% | COM | 83570H108 |
| — | ROIVANT SCIENCES LTD | 1,100,662 | $2,730 | 0.6% | $1.88 | — | *W EXP 09/30/202 | G76279119 |
| OSG | AMBAC FINL GROUP INC | 187,568 | $2,671 | 0.6% | $14.33 | +2.1% | COM NEW | 023139884 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 232,201 | $2,213 | 0.5% | $11.10 | 0.0% | COM | 03969K108 |
| HTZWW | HERTZ GLOBAL HLDGS INC | 123,494 | $1,246 | 0.3% | $10.08 | — | *W EXP 06/30/205 | 42806J148 |
| — | MALLINCKRODT PLC | 585,602 | $691 | 0.2% | $1.37 | — | ORD SHS | G5890A102 |